264 related articles for article (PubMed ID: 10655438)
1. Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells.
Leoni LM; Hamel E; Genini D; Shih H; Carrera CJ; Cottam HB; Carson DA
J Natl Cancer Inst; 2000 Feb; 92(3):217-24. PubMed ID: 10655438
[TBL] [Abstract][Full Text] [Related]
2. Biochemical genetic analysis of indanocine resistance in human leukemia.
Hua XH; Genini D; Gussio R; Tawatao R; Shih H; Kipps TJ; Carson DA; Leoni LM
Cancer Res; 2001 Oct; 61(19):7248-54. PubMed ID: 11585762
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
4. Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes.
Kumbhar BV; Panda D; Kunwar A
PLoS One; 2018; 13(3):e0194934. PubMed ID: 29584771
[TBL] [Abstract][Full Text] [Related]
5. Binding of indanocine to the colchicine site on tubulin promotes fluorescence, and its binding parameters resemble those of the colchicine analogue AC.
Das L; Gupta S; Dasgupta D; Poddar A; Janik ME; Bhattacharyya B
Biochemistry; 2009 Feb; 48(7):1628-35. PubMed ID: 19182899
[TBL] [Abstract][Full Text] [Related]
6. CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line.
Huang YT; Huang DM; Guh JH; Chen IL; Tzeng CC; Teng CM
J Biol Chem; 2005 Jan; 280(4):2771-9. PubMed ID: 15536083
[TBL] [Abstract][Full Text] [Related]
7. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
[TBL] [Abstract][Full Text] [Related]
8. Kinetic stabilization of microtubule dynamics by indanocine perturbs EB1 localization, induces defects in cell polarity and inhibits migration of MDA-MB-231 cells.
Kapoor S; Panda D
Biochem Pharmacol; 2012 Jun; 83(11):1495-506. PubMed ID: 22387536
[TBL] [Abstract][Full Text] [Related]
9. Tubulin/microtubules: still a promising target for new chemotherapeutic agents.
Giannakakou P; Sackett D; Fojo T
J Natl Cancer Inst; 2000 Feb; 92(3):182-3. PubMed ID: 10655426
[No Abstract] [Full Text] [Related]
10. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
[TBL] [Abstract][Full Text] [Related]
11. Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors.
Lin YF; Tsai WP; Liu HG; Liang PH
Cancer Res; 2009 Sep; 69(17):6879-88. PubMed ID: 19690144
[TBL] [Abstract][Full Text] [Related]
12. (4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone inhibits tubulin polymerization, induces G2/M arrest, and triggers apoptosis in human leukemia HL-60 cells.
Magalhães HI; Wilke DV; Bezerra DP; Cavalcanti BC; Rotta R; de Lima DP; Beatriz A; Moraes MO; Diniz-Filho J; Pessoa C
Toxicol Appl Pharmacol; 2013 Oct; 272(1):117-26. PubMed ID: 23756174
[TBL] [Abstract][Full Text] [Related]
13. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
14. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
[TBL] [Abstract][Full Text] [Related]
15. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.
Kasibhatla S; Baichwal V; Cai SX; Roth B; Skvortsova I; Skvortsov S; Lukas P; English NM; Sirisoma N; Drewe J; Pervin A; Tseng B; Carlson RO; Pleiman CM
Cancer Res; 2007 Jun; 67(12):5865-71. PubMed ID: 17575155
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
[TBL] [Abstract][Full Text] [Related]
17. Apicularen A induces cell death through Fas ligand up-regulation and microtubule disruption by tubulin down-regulation in HM7 human colon cancer cells.
Kim JS; Lee YC; Nam HT; Li G; Yun EJ; Song KS; Seo KS; Park JH; Ahn JW; Zee O; Park JI; Yoon WH; Lim K; Hwang BD
Clin Cancer Res; 2007 Nov; 13(21):6509-17. PubMed ID: 17975164
[TBL] [Abstract][Full Text] [Related]
18. An improved synthesis of indanocine and antiproliferative activity of 2-benzylindanocine via microtubule destabilization.
Khwaja S; Fatima K; Mishra D; Babu V; Kumar Y; Malik SB; Tabassum M; Luqman S; Bawankule DU; Chanda D; Khan F; Mondhe DM; Negi AS
Chem Biol Drug Des; 2021 Jul; 98(1):127-143. PubMed ID: 33969634
[TBL] [Abstract][Full Text] [Related]
19. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
[TBL] [Abstract][Full Text] [Related]
20. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
